Procter & Gamble Hygiene and Health Care (500459) Q1 26/27 earnings summary

Executive summary

• Unaudited financial results for the quarter ended June 30, 2026, were approved by the Board on July 29, 2026.

• Financial statements have been reviewed by the Audit Committee and subjected to a limited review by statutory auditors.

Financial highlights

• Revenue from operations for the quarter was ₹88,992 lakh, compared to ₹93,767 lakh in the previous quarter and ₹93,516 lakh in the same quarter last year.

• Profit before tax for the quarter was ₹16,963 lakh, down from ₹21,811 lakh in the previous quarter and ₹26,470 lakh year-over-year.

• Net profit for the quarter was ₹12,627 lakh, compared to ₹15,313 lakh in the previous quarter and ₹19,206 lakh in the same quarter last year.

• Basic and diluted EPS for the quarter were ₹38.90, down from ₹47.17 in the previous quarter and ₹59.17 year-over-year.

Key financial ratios and metrics

• Total expenses for the quarter were ₹73,126 lakh, compared to ₹73,568 lakh in the previous quarter and ₹68,002 lakh year-over-year.

• Paid-up equity share capital stood at ₹3,246 lakh.